United States Glaucoma Medications Market Report 2018

March 2018 | 112 pages | ID: U8F35CB2AAFQEN
QYResearch

Abstracts

In this report, the United States Glaucoma Medications market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Glaucoma Medications in these regions, from 2013 to 2025 (forecast).

United States Glaucoma Medications market competition by top manufacturers/players, with Glaucoma Medications sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Novartis
• bausch Lomb
• Laboratoire Riva
• Jamp Pharma
• Fresenius
• Teva Pharmaceutical?
• SANDOZ
• Greenstone
• Mylan
• GE Medical
• Mint Pharmaceuticals
• Laboratoires Thea
• Taj Pharmaceuticals
• Actavis
• APOTEX
• Sun Pharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Prostaglandin Analogs
• Beta Blockers
• Alpha Agonists
• Carbonic Anhydrase Inhibitors
• Combined Medications

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Open-angle Glaucoma
• Closed-angle Glaucoma

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Glaucoma Medications Market Report 2018

1 GLAUCOMA MEDICATIONS OVERVIEW

1.1 Product Overview and Scope of Glaucoma Medications
1.2 Classification of Glaucoma Medications by Product Category
  1.2.1 United States Glaucoma Medications Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Glaucoma Medications Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Prostaglandin Analogs
  1.2.4 Beta Blockers
  1.2.5 Alpha Agonists
  1.2.6 Carbonic Anhydrase Inhibitors
  1.2.7 Combined Medications
1.3 United States Glaucoma Medications Market by Application/End Users
  1.3.1 United States Glaucoma Medications Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Open-angle Glaucoma
  1.3.3 Closed-angle Glaucoma
1.4 United States Glaucoma Medications Market by Region
  1.4.1 United States Glaucoma Medications Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Glaucoma Medications Status and Prospect (2013-2025)
  1.4.3 Southwest Glaucoma Medications Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Glaucoma Medications Status and Prospect (2013-2025)
  1.4.5 New England Glaucoma Medications Status and Prospect (2013-2025)
  1.4.6 The South Glaucoma Medications Status and Prospect (2013-2025)
  1.4.7 The Midwest Glaucoma Medications Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Glaucoma Medications (2013-2025)
  1.5.1 United States Glaucoma Medications Sales and Growth Rate (2013-2025)
  1.5.2 United States Glaucoma Medications Revenue and Growth Rate (2013-2025)

2 UNITED STATES GLAUCOMA MEDICATIONS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Glaucoma Medications Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Glaucoma Medications Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Glaucoma Medications Average Price by Players/Suppliers (2013-2018)
2.4 United States Glaucoma Medications Market Competitive Situation and Trends
  2.4.1 United States Glaucoma Medications Market Concentration Rate
  2.4.2 United States Glaucoma Medications Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Glaucoma Medications Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GLAUCOMA MEDICATIONS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Glaucoma Medications Sales and Market Share by Region (2013-2018)
3.2 United States Glaucoma Medications Revenue and Market Share by Region (2013-2018)
3.3 United States Glaucoma Medications Price by Region (2013-2018)

4 UNITED STATES GLAUCOMA MEDICATIONS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Glaucoma Medications Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Glaucoma Medications Revenue and Market Share by Type (2013-2018)
4.3 United States Glaucoma Medications Price by Type (2013-2018)
4.4 United States Glaucoma Medications Sales Growth Rate by Type (2013-2018)

5 UNITED STATES GLAUCOMA MEDICATIONS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Glaucoma Medications Sales and Market Share by Application (2013-2018)
5.2 United States Glaucoma Medications Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES GLAUCOMA MEDICATIONS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Glaucoma Medications Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.2 Glaucoma Medications Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 bausch Lomb
  6.3.2 Glaucoma Medications Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 bausch Lomb Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Laboratoire Riva
  6.4.2 Glaucoma Medications Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Laboratoire Riva Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Jamp Pharma
  6.5.2 Glaucoma Medications Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Jamp Pharma Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Fresenius
  6.6.2 Glaucoma Medications Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Fresenius Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Teva Pharmaceutical?
  6.7.2 Glaucoma Medications Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Teva Pharmaceutical? Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 SANDOZ
  6.8.2 Glaucoma Medications Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 SANDOZ Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Greenstone
  6.9.2 Glaucoma Medications Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Greenstone Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Mylan
  6.10.2 Glaucoma Medications Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Mylan Glaucoma Medications Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 GE Medical
6.12 Mint Pharmaceuticals
6.13 Laboratoires Thea
6.14 Taj Pharmaceuticals
6.15 Actavis
6.16 APOTEX
6.17 Sun Pharma

7 GLAUCOMA MEDICATIONS MANUFACTURING COST ANALYSIS

7.1 Glaucoma Medications Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glaucoma Medications

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Glaucoma Medications Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glaucoma Medications Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GLAUCOMA MEDICATIONS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Glaucoma Medications Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Glaucoma Medications Sales Volume Forecast by Type (2018-2025)
11.3 United States Glaucoma Medications Sales Volume Forecast by Application (2018-2025)
11.4 United States Glaucoma Medications Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Glaucoma Medications
Figure United States Glaucoma Medications Market Size (K Units) by Type (2013-2025)
Figure United States Glaucoma Medications Sales Volume Market Share by Type (Product Category) in 2017
Figure Prostaglandin Analogs Product Picture
Figure Beta Blockers Product Picture
Figure Alpha Agonists Product Picture
Figure Carbonic Anhydrase Inhibitors Product Picture
Figure Combined Medications Product Picture
Figure United States Glaucoma Medications Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Glaucoma Medications by Application in 2017
Figure Open-angle Glaucoma Examples
Table Key Downstream Customer in Open-angle Glaucoma
Figure Closed-angle Glaucoma Examples
Table Key Downstream Customer in Closed-angle Glaucoma
Figure United States Glaucoma Medications Market Size (Million USD) by Region (2013-2025)
Figure The West Glaucoma Medications Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Glaucoma Medications Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Glaucoma Medications Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Glaucoma Medications Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Glaucoma Medications Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Glaucoma Medications Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Glaucoma Medications Sales (K Units) and Growth Rate (2013-2025)
Figure United States Glaucoma Medications Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Glaucoma Medications Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Glaucoma Medications Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Glaucoma Medications Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Glaucoma Medications Sales Share by Players/Suppliers
Figure 2017 United States Glaucoma Medications Sales Share by Players/Suppliers
Figure United States Glaucoma Medications Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Glaucoma Medications Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Glaucoma Medications Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Glaucoma Medications Revenue Share by Players/Suppliers
Figure 2017 United States Glaucoma Medications Revenue Share by Players/Suppliers
Table United States Market Glaucoma Medications Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Glaucoma Medications Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Glaucoma Medications Market Share of Top 3 Players/Suppliers
Figure United States Glaucoma Medications Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Glaucoma Medications Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Glaucoma Medications Product Category
Table United States Glaucoma Medications Sales (K Units) by Region (2013-2018)
Table United States Glaucoma Medications Sales Share by Region (2013-2018)
Figure United States Glaucoma Medications Sales Share by Region (2013-2018)
Figure United States Glaucoma Medications Sales Market Share by Region in 2017
Table United States Glaucoma Medications Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Glaucoma Medications Revenue Share by Region (2013-2018)
Figure United States Glaucoma Medications Revenue Market Share by Region (2013-2018)
Figure United States Glaucoma Medications Revenue Market Share by Region in 2017
Table United States Glaucoma Medications Price (USD/Unit) by Region (2013-2018)
Table United States Glaucoma Medications Sales (K Units) by Type (2013-2018)
Table United States Glaucoma Medications Sales Share by Type (2013-2018)
Figure United States Glaucoma Medications Sales Share by Type (2013-2018)
Figure United States Glaucoma Medications Sales Market Share by Type in 2017
Table United States Glaucoma Medications Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Glaucoma Medications Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Glaucoma Medications by Type (2013-2018)
Figure Revenue Market Share of Glaucoma Medications by Type in 2017
Table United States Glaucoma Medications Price (USD/Unit) by Types (2013-2018)
Figure United States Glaucoma Medications Sales Growth Rate by Type (2013-2018)
Table United States Glaucoma Medications Sales (K Units) by Application (2013-2018)
Table United States Glaucoma Medications Sales Market Share by Application (2013-2018)
Figure United States Glaucoma Medications Sales Market Share by Application (2013-2018)
Figure United States Glaucoma Medications Sales Market Share by Application in 2017
Table United States Glaucoma Medications Sales Growth Rate by Application (2013-2018)
Figure United States Glaucoma Medications Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Glaucoma Medications Sales Growth Rate (2013-2018)
Figure Pfizer Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure Pfizer Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Glaucoma Medications Sales Growth Rate (2013-2018)
Figure Novartis Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure Novartis Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table bausch Lomb Basic Information List
Table bausch Lomb Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure bausch Lomb Glaucoma Medications Sales Growth Rate (2013-2018)
Figure bausch Lomb Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure bausch Lomb Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table Laboratoire Riva Basic Information List
Table Laboratoire Riva Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Laboratoire Riva Glaucoma Medications Sales Growth Rate (2013-2018)
Figure Laboratoire Riva Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure Laboratoire Riva Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table Jamp Pharma Basic Information List
Table Jamp Pharma Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Jamp Pharma Glaucoma Medications Sales Growth Rate (2013-2018)
Figure Jamp Pharma Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure Jamp Pharma Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table Fresenius Basic Information List
Table Fresenius Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Fresenius Glaucoma Medications Sales Growth Rate (2013-2018)
Figure Fresenius Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure Fresenius Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table Teva Pharmaceutical? Basic Information List
Table Teva Pharmaceutical? Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical? Glaucoma Medications Sales Growth Rate (2013-2018)
Figure Teva Pharmaceutical? Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure Teva Pharmaceutical? Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table SANDOZ Basic Information List
Table SANDOZ Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure SANDOZ Glaucoma Medications Sales Growth Rate (2013-2018)
Figure SANDOZ Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure SANDOZ Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table Greenstone Basic Information List
Table Greenstone Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Greenstone Glaucoma Medications Sales Growth Rate (2013-2018)
Figure Greenstone Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure Greenstone Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table Mylan Basic Information List
Table Mylan Glaucoma Medications Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan Glaucoma Medications Sales Growth Rate (2013-2018)
Figure Mylan Glaucoma Medications Sales Market Share in United States (2013-2018)
Figure Mylan Glaucoma Medications Revenue Market Share in United States (2013-2018)
Table GE Medical Basic Information List
Table Mint Pharmaceuticals Basic Information List
Table Laboratoires Thea Basic Information List
Table Taj Pharmaceuticals Basic Information List
Table Actavis Basic Information List
Table APOTEX Basic Information List
Table Sun Pharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glaucoma Medications
Figure Manufacturing Process Analysis of Glaucoma Medications
Figure Glaucoma Medications Industrial Chain Analysis
Table Raw Materials Sources of Glaucoma Medications Major Players/Suppliers in 2017
Table Major Buyers of Glaucoma Medications
Table Distributors/Traders List
Figure United States Glaucoma Medications Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Glaucoma Medications Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Glaucoma Medications Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Glaucoma Medications Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Glaucoma Medications Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Glaucoma Medications Sales Volume (K Units) Forecast by Type in 2025
Table United States Glaucoma Medications Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Glaucoma Medications Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Glaucoma Medications Sales Volume (K Units) Forecast by Application in 2025
Table United States Glaucoma Medications Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Glaucoma Medications Sales Volume Share Forecast by Region (2018-2025)
Figure United States Glaucoma Medications Sales Volume Share Forecast by Region (2018-2025)
Figure United States Glaucoma Medications Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources